  See all
 |
Articles: Colorectal Cancer/Polyps |
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer
British Journal of Cancer, 11/20/09
Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
British Journal of Cancer, 11/20/09 Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
British Journal of Cancer, 11/20/09 Prognostic relevance of DNA copy number changes in colorectal cancer
The Journal of Pathology, 11/20/09 
Prior Articles
Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers
Virchows Archiv, 11/19/09
Exclusive Author Commentary Colonic carcinoma with a pancreatic acinar cell differentiation. A case report
Virchows Archiv, 11/19/09 Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells
Molecular Carcinogenesis, 11/19/09 Visceral Fat Volume and the Prevalence of Colorectal Adenoma
American Journal of Epidemiology, 11/19/09 The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens
Journal of Cancer Research & Clinical Oncology, 11/18/09
Exclusive Author Commentary Screening of potential molecular targets for colorectal cancer therapy
International Journal of General Medicine, 11/18/09
Free full text
Effect of bevacizumab in older patients with metastatic colorectal cancer: Pooled analysis of four randomized studies
Journal of Cancer Research & Clinical Oncology, 11/17/09 Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases
Annals of Oncology, 11/16/09 Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies
Annals of Oncology, 11/16/09 Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
Annals of Oncology, 11/16/09
Exclusive Author Commentary PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients
Clinical Cancer Research, 11/16/09 Getting Knit-PI3Ky: PIK3CA Mutation Status to Direct Multimodality Therapy
Clinical Cancer Research, 11/16/09 Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines
Cancer Science, 11/16/09 Triptolide simultaneously induces reactive oxygen species, inhibits NF-kappaB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines
Cancer Letters, 11/16/09 Prognostic Value of Serum Tumor Antigen CA19-9 After Curative Resection of Colorectal Cancer
Anticancer Research, 11/13/09 Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
Journal of Clinical Oncology, 11/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
